Literature DB >> 23986344

γδ T cells predict outcome in zoledronate-treated breast cancer patients.

Joanne L Welton, Salvador Martí, Mohammed H Mahdi, Clare Boobier, Peter J Barrett-Lee, Matthias Eberl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23986344      PMCID： PMC3755939          DOI： 10.1634/theoncologist.2013-0097

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  9 in total

1.  Adjuvant zoledronic acid for breast cancer: mechanism of action?

Authors:  Volker Kunzmann; Martin Wilhelm
Journal:  Lancet Oncol       Date:  2011-10       Impact factor: 41.316

Review 2.  The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.

Authors:  Tingting Yan; Wenjin Yin; Qiong Zhou; Liheng Zhou; Yiwei Jiang; Yueyao Du; Zhimin Shao; Jinsong Lu
Journal:  Eur J Cancer       Date:  2011-11-17       Impact factor: 9.162

3.  In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.

Authors:  S Meraviglia; M Eberl; D Vermijlen; M Todaro; S Buccheri; G Cicero; C La Mendola; G Guggino; M D'Asaro; V Orlando; F Scarpa; A Roberts; N Caccamo; G Stassi; F Dieli; A C Hayday
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

4.  In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients.

Authors:  Daniele Santini; Federico Martini; Maria Elisabetta Fratto; Sara Galluzzo; Bruno Vincenzi; Chiara Agrati; Federica Turchi; Paola Piacentini; Laura Rocci; John S Manavalan; Giuseppe Tonini; Fabrizio Poccia
Journal:  Cancer Immunol Immunother       Date:  2008-05-06       Impact factor: 6.968

Review 5.  What lessons can be learned from γδ T cell-based cancer immunotherapy trials?

Authors:  Jean-Jacques Fournié; Hélène Sicard; Mary Poupot; Christine Bezombes; Amandine Blanc; François Romagné; Loic Ysebaert; Guy Laurent
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

Review 6.  Adjuvant bisphosphonates: a new standard of care?

Authors:  Michael Gnant
Journal:  Curr Opin Oncol       Date:  2012-11       Impact factor: 3.645

7.  Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis.

Authors:  Antonis Valachis; Nikolaos P Polyzos; Robert E Coleman; Michael Gnant; Holger Eidtmann; Adam M Brufsky; Rebecca Aft; Amye J Tevaarwerk; Karen Swenson; Pehr Lind; Davide Mauri
Journal:  Oncologist       Date:  2013-02-12

8.  Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.

Authors:  Joanne L Welton; Matt P Morgan; Salvador Martí; Michael D Stone; Bernhard Moser; Andrew K Sewell; Jane Turton; Matthias Eberl
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

Review 9.  Zoledronic acid as an adjuvant therapy in patients with breast cancer: a systematic review and meta-analysis.

Authors:  Wei-Wei Huang; Cheng Huang; Jian Liu; Hong-Yu Zheng; Lin Lin
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240
  9 in total
  5 in total

1.  In reply.

Authors:  Antonis Valachis; Nikolaos P Polyzos
Journal:  Oncologist       Date:  2013

Review 2.  The best of both worlds - managing the cancer, saving the bone.

Authors:  Issam Makhoul; Corey O Montgomery; Dana Gaddy; Larry J Suva
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

Review 3.  Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells.

Authors:  Matthias Eberl; Ida M Friberg; Anna Rita Liuzzi; Matt P Morgan; Nicholas Topley
Journal:  Front Immunol       Date:  2014-11-13       Impact factor: 7.561

4.  Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome.

Authors:  Francesca Toia; Simona Buccheri; Ampelio Anfosso; Francesco Moschella; Francesco Dieli; Serena Meraviglia; Adriana Cordova
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

5.  Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.

Authors:  Hung-Chang Chen; Noémie Joalland; John S Bridgeman; Fouad S Alchami; Ulrich Jarry; Mohd Wajid A Khan; Luke Piggott; Yasmin Shanneik; Jianqiang Li; Marco J Herold; Thomas Herrmann; David A Price; Awen M Gallimore; Richard W Clarkson; Emmanuel Scotet; Bernhard Moser; Matthias Eberl
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.